EMMII App for Menopause
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a mobile app, called EMMII, can help women manage menopause symptoms more effectively. The goal is to determine if the app improves their experience and reduces the need for additional healthcare. Participants will either use the EMMII app or receive educational materials from the Mayo Clinic. The trial seeks women experiencing menopause symptoms who have an upcoming Mayo Clinic appointment. As an unphased trial, it offers participants the opportunity to contribute to innovative research that could enhance menopause management for many women.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this app is safe for menopause-related health care utilization?
Research has shown that healthcare experts helped create the EMMII app for menopause to assist women in managing menopause symptoms. The app provides educational content and enables users to track their symptoms. Although no specific safety issues have been reported for the EMMII app itself, it is important to remember that it serves as a digital tool, not a medical treatment. Users primarily engage with information and tracking features, which are generally safe. The app aims to empower women to understand and manage their menopause symptoms with confidence.12345
Why are researchers excited about this trial?
Researchers are excited about the EMMII App for menopause because it offers a unique, interactive approach to managing menopause symptoms. Unlike traditional treatments that often involve hormone replacement therapy or medications, EMMII focuses on empowering women through education and self-awareness. The app helps users identify their symptoms and encourages confidence in seeking appropriate treatments, potentially leading to more personalized and effective care. This digital tool leverages technology to provide tailored information and support, making it stand out from conventional pamphlet-based education.
What evidence suggests that the EMMII app is effective for improving menopause symptoms?
Research has shown that doctors specializing in menopause helped create the EMMII app. This app includes tools such as symptom tracking and personalized treatment advice. It aids women in understanding their menopause symptoms and boosts their confidence in seeking treatment. Participants in this trial will use the EMMII app, which early studies suggest may ease the management of menopause symptoms by providing reliable guidance. The app's educational features aim to empower users to take control of their health during menopause. Meanwhile, the comparison group in this trial will receive the Mayo Clinic Patient Education Pamphlet "Perimenopause & Menopause."12456
Are You a Good Fit for This Trial?
This trial is for English-speaking women aged 45-55 who are experiencing menopause symptoms, as indicated by a Menopause Rating Scale score of ≥5. Participants must be able to consent and have an upcoming primary care appointment at Mayo Clinic within 3 weeks of enrollment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the EMMII app or receive educational pamphlets to manage menopause symptoms
Follow-up
Participants are monitored for changes in menopause-related health care utilization and symptom management effectiveness
What Are the Treatments Tested in This Trial?
Interventions
- Comparison Group
- EMMII
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor